Anti-Melanoma [LHM3]
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152695 |
Applications | IHC IF IP WB |
Antigen/Gene or Protein Targets | Melanoma |
Reactivity | Human |
Relevance | LHM3 can be used in a diagnostic panel for immunopathology of malignant melanoma. Potential candidate for immunoimaging and immunotherapy of disseminated melanoma. |
Host | Mouse |
Immunogen | A 375P cell extract |
Subclass | IgG1 kappa |
Molecular Weight (kDa) | 120 |
Recommended Growing Conditions | DMEM + 5% FCS |
Research Area | Cancer, Cell Type or Organelle Marker |
References: 2 entries
Kupsch et al. 1995. Melanoma Res. 5(6):403-11. PMID: 8589614.
Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
Europe PMC ID: 8589614
Add a reference
References: 2 entries
Kupsch et al. 1995. Melanoma Res. 5(6):403-11. PMID: 8589614.
Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
Add a reference